[1]
Matikainen N, Pekkarinen T, Ryhänen EM, Schalin-Jäntti C. Physiology of Calcium Homeostasis: An Overview. Endocrinology and metabolism clinics of North America. 2021 Dec:50(4):575-590. doi: 10.1016/j.ecl.2021.07.005. Epub
[PubMed PMID: 34774235]
Level 3 (low-level) evidence
[2]
Gafni RI, Collins MT. Hypoparathyroidism. The New England journal of medicine. 2019 May 2:380(18):1738-1747. doi: 10.1056/NEJMcp1800213. Epub
[PubMed PMID: 31042826]
[3]
Bilezikian JP. Hypoparathyroidism. The Journal of clinical endocrinology and metabolism. 2020 Jun 1:105(6):1722-36. doi: 10.1210/clinem/dgaa113. Epub
[PubMed PMID: 32322899]
[4]
Abate EG, Clarke BL. Review of Hypoparathyroidism. Frontiers in endocrinology. 2016:7():172. doi: 10.3389/fendo.2016.00172. Epub 2017 Jan 16
[PubMed PMID: 28138323]
[5]
Khan AA, Bilezikian JP, Brandi ML, Clarke BL, Gittoes NJ, Pasieka JL, Rejnmark L, Shoback DM, Potts JT, Guyatt GH, Mannstadt M. Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2022 Dec:37(12):2568-2585. doi: 10.1002/jbmr.4691. Epub 2022 Nov 14
[PubMed PMID: 36054621]
[6]
Yao L, Guyatt G, Ye Z, Bilezikian JP, Brandi ML, Clarke BL, Mannstadt M, Khan AA. Methodology for the Guidelines on Evaluation and Management of Hypoparathyroidism and Primary Hyperparathyroidism. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2022 Nov:37(11):2404-2410. doi: 10.1002/jbmr.4687. Epub 2022 Oct 17
[PubMed PMID: 36053800]
[7]
Mannstadt M, Cianferotti L, Gafni RI, Giusti F, Kemp EH, Koch CA, Roszko KL, Yao L, Guyatt GH, Thakker RV, Xia W, Brandi ML. Hypoparathyroidism: Genetics and Diagnosis. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2022 Dec:37(12):2615-2629. doi: 10.1002/jbmr.4667. Epub 2022 Nov 14
[PubMed PMID: 36375809]
[8]
Van Uum S, Shrayyef M, M'Hiri I, Dandurand K, Ali DS, Bilezikian JP, Collins MT, Mannstadt M, Rubin MR, Siggelkow H, Tabacco G, Tay YD, Vokes T, Winer KK, Yao L, Guyatt G, Rejnmark L, Khan AA. Initial Assessment and Monitoring of Patients with Chronic Hypoparathyroidism: A Systematic Current Practice Survey. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2022 Dec:37(12):2630-2641. doi: 10.1002/jbmr.4698. Epub 2022 Nov 14
[PubMed PMID: 36066096]
Level 1 (high-level) evidence
[9]
Yao L, Hui X, Li M, Li J, Ahmed MM, Lin C, Kandi M, Sreekanta A, Makhdami N, Tamilselvan D, Ali DS, Dandurand K, Yang K, Bilezikian JP, Brandi ML, Clarke BL, Mannstadt M, Rejnmark L, Khan AA, Guyatt G. Complications, Symptoms, Presurgical Predictors in Patients With Chronic Hypoparathyroidism: A Systematic Review. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2022 Dec:37(12):2642-2653. doi: 10.1002/jbmr.4673. Epub 2022 Nov 14
[PubMed PMID: 36375810]
Level 1 (high-level) evidence
[10]
Rayannavar A, Levitt Katz LE, Crowley TB, Lessig M, Grand K, Goldmuntz E, Zackai EH, McDonald-McGinn DM. Association of hypocalcemia with congenital heart disease in 22q11.2 deletion syndrome. American journal of medical genetics. Part A. 2018 Oct:176(10):2099-2103. doi: 10.1002/ajmg.a.40495. Epub 2018 Oct 1
[PubMed PMID: 30277015]
[11]
Cianferotti L, Marcucci G, Brandi ML. Causes and pathophysiology of hypoparathyroidism. Best practice & research. Clinical endocrinology & metabolism. 2018 Dec:32(6):909-925. doi: 10.1016/j.beem.2018.07.001. Epub 2018 Jul 29
[PubMed PMID: 30665552]
[12]
Ehrenpreis ED, Jarrouj G, Meader R, Wagner C, Ellis M. A comprehensive review of hypomagnesemia. Disease-a-month : DM. 2022 Feb:68(2):101285. doi: 10.1016/j.disamonth.2021.101285. Epub 2021 Sep 10
[PubMed PMID: 34511254]
[13]
Bjornsdottir S, Ing S, Mitchell DM, Sikjaer T, Underbjerg L, Hassan-Smith Z, Sfeir J, Gittoes NJ, Clarke L BL. Epidemiology and Financial Burden of Adult Chronic Hypoparathyroidism. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2022 Dec:37(12):2602-2614. doi: 10.1002/jbmr.4675. Epub 2022 Aug 29
[PubMed PMID: 36054571]
[14]
Rao SD. Epidemiology of parathyroid disorders. Best practice & research. Clinical endocrinology & metabolism. 2018 Dec:32(6):773-780. doi: 10.1016/j.beem.2018.12.003. Epub 2018 Dec 7
[PubMed PMID: 30559041]
[15]
Tinawi M. Disorders of Calcium Metabolism: Hypocalcemia and Hypercalcemia. Cureus. 2021 Jan 1:13(1):e12420. doi: 10.7759/cureus.12420. Epub 2021 Jan 1
[PubMed PMID: 33542868]
[16]
Bove-Fenderson E, Mannstadt M. Hypocalcemic disorders. Best practice & research. Clinical endocrinology & metabolism. 2018 Oct:32(5):639-656. doi: 10.1016/j.beem.2018.05.006. Epub 2018 May 28
[PubMed PMID: 30449546]
[17]
Khan AA, Guyatt G, Ali DS, Bilezikian JP, Collins MT, Dandurand K, Mannstadt M, Murphy D, M'Hiri I, Rubin MR, Sanders R, Shrayyef M, Siggelkow H, Tabacco G, Tay YD, Van Uum S, Vokes T, Winer KK, Yao L, Rejnmark L. Management of Hypoparathyroidism. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2022 Dec:37(12):2663-2677. doi: 10.1002/jbmr.4716. Epub 2022 Oct 31
[PubMed PMID: 36161671]
[18]
Marcucci G, Cianferotti L, Brandi ML. Clinical presentation and management of hypoparathyroidism. Best practice & research. Clinical endocrinology & metabolism. 2018 Dec:32(6):927-939. doi: 10.1016/j.beem.2018.09.007. Epub 2018 Sep 28
[PubMed PMID: 30665553]
[19]
Di Maio S, Soliman AT, De Sanctis V, Kattamis CC. Current treatment of hypoparathyroidism: Theory versus reality waiting guidelines for children and adolescents. Acta bio-medica : Atenei Parmensis. 2018 Mar 27:89(1):122-131. doi: 10.23750/abm.v89i1.7118. Epub 2018 Mar 27
[PubMed PMID: 29633734]
[20]
Bollerslev J, Rejnmark L, Zahn A, Heck A, Appelman-Dijkstra NM, Cardoso L, Hannan FM, Cetani F, Sikjær T, Formenti AM, Björnsdottir S, Schalin-Jantti C, Belaya Z, Gibb FW, Lapauw B, Amrein K, Wicke C, Grasemann C, Krebs M, Ryhänen EM, Makay O, Minisola S, Gaujoux S, Bertocchio JP, Hassan-Smith ZK, Linglart A, Winter EM, Kollmann M, Zmierczak HG, Tsourdi E, Pilz S, Siggelkow H, Gittoes NJ, Marcocci C, Kamenicky P, 2021 PARAT Working Group. European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders. European journal of endocrinology. 2022 Feb 1:186(2):R33-R63. doi: 10.1530/EJE-21-1044. Epub 2022 Jan 13
[PubMed PMID: 34863037]
Level 3 (low-level) evidence
[21]
Gosmanova EO, Chen K, Rejnmark L, Mu F, Swallow E, Briggs A, Ayodele O, Sherry N, Ketteler M. Risk of Chronic Kidney Disease and Estimated Glomerular Filtration Rate Decline in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study. Advances in therapy. 2021 Apr:38(4):1876-1888. doi: 10.1007/s12325-021-01658-1. Epub 2021 Mar 9
[PubMed PMID: 33687651]
Level 2 (mid-level) evidence
[22]
Khan AA, Rubin MR, Schwarz P, Vokes T, Shoback DM, Gagnon C, Palermo A, Marcocci C, Clarke BL, Abbott LG, Hofbauer LC, Kohlmeier L, Pihl S, An X, Eng WF, Smith AR, Ukena J, Sibley CT, Shu AD, Rejnmark L. Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2023 Jan:38(1):14-25. doi: 10.1002/jbmr.4726. Epub 2022 Nov 12
[PubMed PMID: 36271471]
[23]
Yao L, Li J, Li M, Lin C, Hui X, Tamilselvan D, Kandi M, Sreekanta A, Makhdami N, Ali DS, Dandurand K, Yang K, Bilezikian JP, Brandi ML, Clarke BL, Mannstadt M, Rejnmark L, Khan AA, Guyatt G. Parathyroid Hormone Therapy for Managing Chronic Hypoparathyroidism: A Systematic Review and Meta-Analysis. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2022 Dec:37(12):2654-2662. doi: 10.1002/jbmr.4676. Epub 2022 Nov 16
[PubMed PMID: 36385517]
Level 1 (high-level) evidence
[24]
Holmes EW, Samarasinghe S, Emanuele MA, Meah F. Biotin Interference in Clinical Immunoassays: A Cause for Concern. Archives of pathology & laboratory medicine. 2017 Nov:141(11):1459-1460. doi: 10.5858/arpa.2017-0107-LE. Epub
[PubMed PMID: 29072950]
[25]
Hakami Y, Khan A. Hypoparathyroidism. Frontiers of hormone research. 2019:51():109-126. doi: 10.1159/000491042. Epub 2018 Nov 19
[PubMed PMID: 30641528]
[26]
Linglart A, Levine MA, Jüppner H. Pseudohypoparathyroidism. Endocrinology and metabolism clinics of North America. 2018 Dec:47(4):865-888. doi: 10.1016/j.ecl.2018.07.011. Epub 2018 Oct 12
[PubMed PMID: 30390819]
[27]
Pepe J, Colangelo L, Biamonte F, Sonato C, Danese VC, Cecchetti V, Occhiuto M, Piazzolla V, De Martino V, Ferrone F, Minisola S, Cipriani C. Diagnosis and management of hypocalcemia. Endocrine. 2020 Sep:69(3):485-495. doi: 10.1007/s12020-020-02324-2. Epub 2020 May 4
[PubMed PMID: 32367335]
[28]
Dershem R, Gorvin CM, Metpally RPR, Krishnamurthy S, Smelser DT, Hannan FM, Carey DJ, Thakker RV, Breitwieser GE, Regeneron Genetics Center. Familial Hypocalciuric Hypercalcemia Type 1 and Autosomal-Dominant Hypocalcemia Type 1: Prevalence in a Large Healthcare Population. American journal of human genetics. 2020 Jun 4:106(6):734-747. doi: 10.1016/j.ajhg.2020.04.006. Epub 2020 May 7
[PubMed PMID: 32386559]